Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Director acquired 2,145 shares (grant or award)
  3. 4 Grant or award Director acquired 2,145 shares (grant or award)
  4. 4 Grant or award Director acquired 2,145 shares (grant or award)
  5. 4 Grant or award Director acquired 2,145 shares (grant or award)
  6. 4 Grant or award Director acquired 2,145 shares (grant or award)
  7. 4 Grant or award Director acquired 2,145 shares (grant or award)
  8. 4 Grant or award Director acquired 2,145 shares (grant or award)
  9. 4 Open-market sale EVP & Chief Commercial Officer sold 1,009 shares at an average $94.82 ($95,670)
  10. 4 Open-market sale EVP and General Counsel sold 1,329 shares at $100.00 ($132,900)
  11. 4 Open-market sale EVP & Chief Tech Ops Officer sold 363 shares at $113.68 ($41,266)
  12. 4 Open-market sale EVP and General Counsel sold 313 shares at $113.67 ($35,579)
  13. 4 Open-market sale Pinion John Richard sold 363 shares at $113.69 ($41,269)
  14. 4 Open-market sale SVP, Chief Accounting Officer sold 142 shares at $113.67 ($16,141)
  15. 4 Open-market sale CBO & EVP sold 363 shares at $113.69 ($41,269)
  16. 4 Shares withheld for taxes President & CEO gave up 852 shares (to pay taxes)
  17. 4 Open-market sale EVP & Chief Commercial Officer sold 700 shares at an average $113.67 ($79,572)
  18. 4 Open-market sale EVP and Chief Medical Officer sold 364 shares at $113.67 ($41,376)
  19. 4 Open-market sale President & CEO sold 30,000 shares at $107.80 ($3,234,000)
  20. 4 Open-market sale EVP & Chief Commercial Officer sold 396 shares at $104.28 ($41,295)

Page 10 of 32 · 627 filings